Zou et al. reported that sclerostin expression in osteosarcoma was lower than that in osteochondroma or normal osteoblasts, and its knockdown in osteosarcoma cell lines resulted in increased proliferation [59]. This evidence concerns the gene SOST and osteosarcoma.